In the past week, BIOR stock has gone down by -9.30%, with a monthly decline of -27.01% and a quarterly plunge of -42.09%. The volatility ratio for the week is 15.34%, and the volatility levels for the last 30 days are 10.76% for Biora Therapeutics Inc The simple moving average for the past 20 days is -22.15% for BIOR’s stock, with a -48.27% simple moving average for the past 200 days.
Is It Worth Investing in Biora Therapeutics Inc (NASDAQ: BIOR) Right Now?
The 36-month beta value for BIOR is also noteworthy at 1.24. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BIOR is 3.41M, and at present, short sellers hold a 4.13% of that float. The average trading volume of BIOR on October 28, 2024 was 30.52K shares.
BIOR) stock’s latest price update
Biora Therapeutics Inc (NASDAQ: BIOR) has experienced a rise in its stock price by 11.43 compared to its previous closing price of 3.50. However, the company has seen a fall of -9.30% in its stock price over the last five trading days. globenewswire.com reported 2024-08-26 that SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will participate in the H.C. Wainwright 26th Annual Global Investment Conference, September 9–11, 2024.
BIOR Trading at -33.67% from the 50-Day Moving Average
After a stumble in the market that brought BIOR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.69% of loss for the given period.
Volatility was left at 10.76%, however, over the last 30 days, the volatility rate increased by 15.34%, as shares sank -24.11% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.40% lower at present.
During the last 5 trading sessions, BIOR fell by -9.30%, which changed the moving average for the period of 200-days by -69.05% in comparison to the 20-day moving average, which settled at $5.01. In addition, Biora Therapeutics Inc saw -71.11% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BIOR
Current profitability levels for the company are sitting at:
- -39.24 for the present operating margin
- 0.74 for the gross margin
The net margin for Biora Therapeutics Inc stands at -49.99. The total capital return value is set at 2.45.
Based on Biora Therapeutics Inc (BIOR), the company’s capital structure generated -1.09 points at debt to capital in total, while cash flow to debt ratio is standing at -1.04. The debt to equity ratio resting at -0.52. The interest coverage ratio of the stock is 24.29.
Currently, EBITDA for the company is -66.59 million with net debt to EBITDA at -0.61. When we switch over and look at the enterprise to sales, we see a ratio of 32.32. The receivables turnover for the company is 2.11for trailing twelve months and the total asset turnover is 0.09. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.20.
Conclusion
In summary, Biora Therapeutics Inc (BIOR) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
